Medtronic Balance Sheet
NYSE: MDTHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medtronic financial position
At the end of fiscal 2026, Medtronic reported total assets of $93.03 billion, up 1.5% from a year earlier against total liabilities of $42.96 billion. Shareholders' equity stood at $49.46 billion, or 53.2% of assets. The company held $1.95 billion in cash and equivalents against $27.96 billion of debt, a net debt position of $26.01 billion.
The current ratio (current assets divided by current liabilities) was 2.13, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.57.
Summary generated from market data by MetaCap's automated system. Methodology
Medtronic balance sheet (annual)
| Fiscal year (USD) | FY 20262026-04-24 | FY 20252025-04-25 | FY 20242024-04-26 | FY 20232023-04-28 | FY 20222022-04-29 | FY 20212021-04-30 | FY 20202020-04-24 | FY 20192019-04-26 | FY 20182018-04-27 | FY 20172017-04-28 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.95B | 2.22B | 1.28B | 1.54B | 3.71B | 3.59B | 4.14B | 4.39B | 3.67B | 4.97B |
| Short-Term Investments | 7.27B | 6.75B | 6.72B | 6.42B | 6.86B | 7.22B | 6.81B | 5.46B | 7.56B | 8.74B |
| Receivables | 6.64B | 6.51B | 6.13B | 6.00B | 5.55B | 5.46B | 4.64B | 6.22B | 5.99B | 5.59B |
| Inventory | 5.95B | 5.48B | 5.22B | 5.29B | 4.62B | 4.31B | 4.23B | 3.75B | 3.58B | 3.34B |
| Total Current Assets | 24.79B | 23.81B | 21.93B | 21.68B | 23.06B | 22.55B | 22.03B | 21.97B | 22.98B | 24.87B |
| Property, Plant & Equipment | 7.42B | 6.84B | 6.13B | 5.57B | 5.41B | 5.22B | 4.83B | 4.67B | 4.60B | 4.36B |
| Goodwill | 42.59B | 41.74B | 40.99B | 41.42B | 40.50B | 41.96B | 39.84B | 39.96B | 39.54B | 38.52B |
| Intangible Assets | 10.15B | 11.67B | 13.22B | 14.84B | 15.60B | 17.74B | 19.06B | 20.56B | 21.72B | 23.41B |
| Total Assets | 93.03B | 91.68B | 89.98B | 90.95B | 90.98B | 93.08B | 90.69B | 89.69B | 91.39B | 99.86B |
| Accounts Payable | 2.64B | 2.45B | 2.41B | 2.66B | 2.28B | 2.11B | 2.00B | 1.95B | 1.63B | 1.55B |
| Short-Term Debt | 1.79B | 2.87B | 1.09B | 20.00M | 3.74B | 11.00M | 2.78B | 838.00M | 2.06B | 7.52B |
| Total Current Liabilities | 11.66B | 12.88B | 10.79B | 9.05B | 12.39B | 8.51B | 10.37B | 8.47B | 10.08B | 14.26B |
| Long-Term Debt | 26.17B | 25.64B | 23.93B | 24.34B | 20.37B | 26.38B | 22.14B | 24.55B | 23.69B | 25.87B |
| Total Liabilities | 42.96B | 43.42B | 39.56B | 39.28B | 38.26B | 41.48B | 39.82B | 39.48B | 40.57B | 49.53B |
| Shareholders' Equity | 49.46B | 48.02B | 50.21B | 51.48B | 52.55B | 51.43B | 50.74B | 50.09B | 50.72B | 50.21B |
| Retained Earnings | 32.64B | 31.48B | 30.40B | 30.39B | 30.25B | 28.59B | 28.13B | 26.27B | 24.38B | 23.27B |
| Total Debt | 27.96B | 28.52B | 25.02B | 24.36B | 24.11B | 26.39B | 24.92B | 25.39B | 25.75B | 33.39B |
| Net Cash (Debt) | -18.74B | -19.55B | -17.02B | -16.41B | -13.54B | -15.57B | -13.97B | -15.54B | -14.52B | -19.69B |
| Shares Outstanding | 1.28B | 1.28B | 1.31B | 1.33B | 1.33B | 1.35B | 1.34B | 1.34B | 1.35B | 1.37B |
This table shows 10 annual periods of Medtronic's balance sheet, from FY 2026 back to FY 2017, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MDT's reporting calendar. What is a balance sheet?